SODIUM SULFACETAMIDE

N/A

Manufactured by Mission Pharmacal Company

367 FDA adverse event reports analyzed

Last updated: 2026-04-15

About SODIUM SULFACETAMIDE

SODIUM SULFACETAMIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Mission Pharmacal Company. The most commonly reported adverse reactions for SODIUM SULFACETAMIDE include DRUG INEFFECTIVE, PAIN, NAUSEA, PRODUCT DOSE OMISSION ISSUE, CONDITION AGGRAVATED. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for SODIUM SULFACETAMIDE.

Top Adverse Reactions

DRUG INEFFECTIVE20 reports
PAIN17 reports
NAUSEA12 reports
PRODUCT DOSE OMISSION ISSUE11 reports
CONDITION AGGRAVATED10 reports
OFF LABEL USE10 reports
FATIGUE7 reports
RASH7 reports
SUICIDAL IDEATION7 reports
ANXIETY5 reports
BACK PAIN5 reports
DEPRESSION5 reports
DYSPNOEA5 reports
FEELING ABNORMAL5 reports
PRURITUS5 reports
PSORIASIS5 reports
SOMNOLENCE5 reports
ACNE4 reports
ANAPHYLACTIC REACTION4 reports
BURNING SENSATION4 reports
COUGH4 reports
DIARRHOEA4 reports
DRUG HYPERSENSITIVITY4 reports
ERYTHEMA4 reports
EYE PAIN4 reports
HEADACHE4 reports
INJURY4 reports
INSOMNIA4 reports
PNEUMONIA4 reports
PRODUCT QUALITY ISSUE4 reports
SINUSITIS4 reports
VOMITING4 reports
ALOPECIA3 reports
ARTHRALGIA3 reports
BLINDNESS3 reports
CEREBROVASCULAR ACCIDENT3 reports
CHEST PAIN3 reports
DRY EYE3 reports
DYSURIA3 reports
EXPOSURE DURING PREGNANCY3 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION3 reports
INFLUENZA3 reports
INTERVERTEBRAL DISC PROTRUSION3 reports
MALAISE3 reports
MEDICATION ERROR3 reports
MEMORY IMPAIRMENT3 reports
NEURALGIA3 reports
NEUROPATHY PERIPHERAL3 reports
PANIC ATTACK3 reports
PARAESTHESIA3 reports
PRODUCT SUBSTITUTION ISSUE3 reports
PRODUCT USE IN UNAPPROVED INDICATION3 reports
PYREXIA3 reports
RHEUMATOID ARTHRITIS3 reports
SKIN BURNING SENSATION3 reports
SURGERY3 reports
THERAPY NON RESPONDER3 reports
VISION BLURRED3 reports
WEIGHT DECREASED3 reports
WEIGHT INCREASED3 reports
WHITE BLOOD CELL COUNT DECREASED3 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS3 reports
ABDOMINAL PAIN2 reports
ACUTE RESPIRATORY DISTRESS SYNDROME2 reports
ADVERSE DRUG REACTION2 reports
ANHEDONIA2 reports
ASTHENIA2 reports
ASTHMA2 reports
BLOOD GLUCOSE INCREASED2 reports
CARDIAC FAILURE2 reports
CHILLS2 reports
CHRONIC KIDNEY DISEASE2 reports
COMA2 reports
CONFUSIONAL STATE2 reports
CONSTIPATION2 reports
CROHN^S DISEASE2 reports
DEAFNESS2 reports
DEEP VEIN THROMBOSIS2 reports
DEPRESSED LEVEL OF CONSCIOUSNESS2 reports
DISCOMFORT2 reports
DISORIENTATION2 reports
DIZZINESS2 reports
DRUG DISPENSING ERROR2 reports
DYSPEPSIA2 reports
EYE DISCHARGE2 reports
EYE INFECTION2 reports
EYE IRRITATION2 reports
EYE SWELLING2 reports
FALL2 reports
FUNGAL INFECTION2 reports
GASTROINTESTINAL DISORDER2 reports
HEART RATE INCREASED2 reports
HYPERSENSITIVITY2 reports
HYPOAESTHESIA2 reports
ILL DEFINED DISORDER2 reports
ILLNESS2 reports
INCORRECT DOSE ADMINISTERED2 reports
INTENTIONAL PRODUCT USE ISSUE2 reports
LACRIMATION INCREASED2 reports
LYMPHADENOPATHY2 reports

Report Outcomes

Out of 175 classified reports for SODIUM SULFACETAMIDE:

Serious 38.3%Non-Serious 61.7%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female107 (64.5%)
Male59 (35.5%)

Reports by Age

Age 496 reports
Age 625 reports
Age 264 reports
Age 404 reports
Age 524 reports
Age 734 reports
Age 183 reports
Age 243 reports
Age 283 reports
Age 463 reports
Age 483 reports
Age 703 reports
Age 222 reports
Age 312 reports
Age 342 reports
Age 352 reports
Age 362 reports
Age 372 reports
Age 412 reports
Age 432 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with SODIUM SULFACETAMIDE?

This profile reflects 367 FDA FAERS reports that mention SODIUM SULFACETAMIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for SODIUM SULFACETAMIDE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, PAIN, NAUSEA, PRODUCT DOSE OMISSION ISSUE, CONDITION AGGRAVATED, OFF LABEL USE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures SODIUM SULFACETAMIDE?

Labeling and FAERS entries often list Mission Pharmacal Company in connection with SODIUM SULFACETAMIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.